Study identifies rapidly dividing cancer stem cells that can respond to new therapies
Brain cancers have long been thought of as being resistant to treatments because of the presence of multiple types of cancer cells within each tumor. A new study uncovers a cancer cell hierarchy that originates from a single cancer cell type, which can be targeted to slow cancer growth.
Providing excellent care and the latest research to help patients
The Brain Tumour Foundation of Canada estimates that 27 Canadians a day are diagnosed with a brain tumour and 55,000 are living with one. This Brain Tumour Awareness Week we recognize the toll this disease takes on patients and the work being done to improve their quality of life.
Brain cancer begins in stem cells, targeting them may prevent tumour growth
Researchers at the Montreal Neurological Institute and Hospital (The Neuro) have found an exciting new way of treating brain cancer.
Late stage brain cancer cells are heterogeneous — they differ down to the molecular level. This makes developing treatments at this stage difficult, because a drug that may be effective against one cell may not be effective against another.
Québec Science magazine’s 25-year tradition continues: every fall, a jury comprised of researchers and journalists selects the top 10 most impressive discoveries in Quebec in the past year and the public is asked to vote to select the winner. This year, a cancer-detection probe was chosen by nearly a third of approximately 4,400 votes cast in the 2017 Discovery of the Year contest.
Québec Science magazine has selected its 10 Discoveries of the Year for 2017, including three involving McGill researchers. The annual list has highlighted top scientific research from across Quebec for the past 25 years, and McGill has been cited more than any other institution during that quarter-century.
Here are the selected discoveries involving McGill scientists for the past year:
A night dedicated to the memory of those lost to brain cancer and in honour of those still fighting the disease will raise money for research that will lead to better treatments.
Patients with common widespread forms of cancer will enjoy longer life expectancy and reduced risk of recurrence thanks to a multimodal optical spectroscopy probe developed by Canadian researchers.
A Brilliant Night raises $1 million for brain cancer research
A Brilliant Night raised an astounding $1 million for brain cancer research at its gala event on Oct. 19.
Inspiring event to raise money for brain cancer research
An evening filled with personal stories from those whose lives have been affected by brain cancer will once again contribute to the fight against the disease.
Fundraiser to support research to help defeat cancer suffered by Tragically Hip frontman
With the farewell concert of legendary Canadian band The Tragically Hip now past, The Neuro is asking the public to not forget the toll brain cancers take on Canadians, and the need to find new therapies.
Dr.
Montreal, Quebec (October 22, 2015) – Last night the inaugural A Brilliant Night - a gala fundraiser to benefit The Montreal Neurological Institute and Hospital -The Neuro- at McGill University and the MUHC, raised more than $604,000 for brain tumour research.
Join us for the first edition of A Brilliant Night at the spectacular new Rio Tinto Alcan Planetarium in Montreal for a unique event on October 21st to support the latest in brain tumor research at the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the McGill University Health Centre.
A BRILLIANT CAUSE
